Nipride RTU
- Generic Name: sodium nitroprusside injection
- Brand Name: Nipride RTU
- Drug Class: Vasodilators
Nipride RTU(Sodium Nitroprusside Injection) side effects drug center
Nipride RTU Side Effects Center
Nipride RTU (sodium nitroprusside) in 0.9% sodium chloride injection is a direct acting vasodilator indicated for immediate reduction of blood pressure; producing controlled hypotension to reduce bleeding during surgery; and treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure. Common side effects of Nipride RTU can be serious and include:
- low blood pressure (hypotension), and
- cyanide toxicity,
- thiocyanate toxicity,
- blood disorder (methemoglobinemia), and
- increases in intracranial pressure.
Less common side effects of Nipride RTU include:
- slow or fast heart rate,
- rash,
- nausea,
- abdominal pain,
- muscle twitching,
- dizziness,
- headache,
- flushing,
- sweating,
- red streaking along the veins, and
- irritation at the infusion site.
Initiate infusion of Nipride RTU at a rate of 0.3 mcg/kg/min, and titrate every few minutes until the desired effect is achieved OR the maximum recommended infusion rate of 10 mcg/kg/min has been reached. Nipride RTU may interact with other drugs in the same solution. Tell your doctor all medications and supplements you use. Nipride RTU is not recommended for use during pregnancy; it may harm a fetus. It is unknown if Nipride RTU passes into breast milk. Consult your doctor before breastfeeding.
Our Nipride RTU (sodium nitroprusside) in 0.9% Sodium Chloride Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Nipride RTU Consumer Information
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:
- feeling like you might pass out, even while lying down;
- gasping, struggling to breathe, or shallow breathing;
- confusion, ringing in your ears;
- dizziness with nausea and vomiting, rapid breathing, seizure (convulsions);
- fast, slow, or uneven heart rate;
- numb or cold feeling in your arms and legs; or
- chills, sweating, tremors, twitching, overactive reflexes.
Less serious side effects may include:
- mild skin rash;
- mild stomach pain or nausea;
- warmth, redness, or tingly feeling under your skin;
- darkening or deeper color of veins through your skin; or
- irritation around the IV needle.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Nipride RTU (Sodium Nitroprusside Injection)
Nipride RTU Professional Information
SIDE EFFECTS
The following adverse reactions are described, or described in greater detail, in other sections:
- Hypotension [see WARNINGS AND PRECAUTIONS]
- Cyanide Toxicity [see WARNINGS AND PRECAUTIONS]
- Thiocyanate Toxicity [see WARNINGS AND PRECAUTIONS]
- Methemoglobinemia [see WARNINGS AND PRECAUTIONS]
- Increased Intracranial Pressure [see WARNINGS AND PRECAUTIONS]
- Anemia and Hypovolemia [see WARNINGS AND PRECAUTIONS]
Less common adverse reactions include:
Cardiovascular: Bradycardia, electrocardiographic changes, tachycardia, palpitations, retrosternal discomfort
Dermatologic: Rash
Endocrine: Hypothyroidism
Gastrointestinal: Ileus, nausea, abdominal pain
Hematologic: Decreased platelet aggregation
Musculoskelatal: Muscle twitching
Neurologic: Increased intracranial pressure, dizziness, headache
Miscellaneous: Flushing, diaphoresis, venous streaking, irritation at the infusion site
Read the entire FDA prescribing information for Nipride RTU (Sodium Nitroprusside Injection)
&Copy; Nipride RTU Patient Information is supplied by Cerner Multum, Inc. and Nipride RTU Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.